On October 29, 2025, Thomas Sweeney resigned as Chief Financial Officer of Oaktree Acquisition Corp. III Life Sciences, and George A. Martinez was appointed as his replacement, effective immediately. This resignation was voluntary, and Mr. Martinez has extensive experience in finance but will not receive compensation or an employment agreement from the company.